BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10101728)

  • 1. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P; Brambilla F; Bortolotti F; Ferraro C; Maj M
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P
    Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB; Williamson DJ; Cowen PJ
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration.
    O'Keane V; O'Hanlon M; Webb M; Dinan T
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):289-92. PubMed ID: 1879060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted fenfluramine-evoked prolactin secretion in hypertensive rats.
    Stocker SD; Muldoon MF; Sved AF
    Hypertension; 2003 Oct; 42(4):719-24. PubMed ID: 12885788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
    van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relationship between central serotonergic neurotransmission and blood pressure in alcohol-dependent male subjects.
    Balldin J; Andersson M; Berggren U; Engel J; Eriksson M; Fahlke C
    J Neural Transm (Vienna); 2006 Oct; 113(10):1511-7. PubMed ID: 16465459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.